1. INTRODUCTION

1.1 Key Deliverables of the Study

1.2 Study Assumptions

1.3 Market Definition

2. RESEARCH APPROACH & METHODOLOGY

2.1 Introduction

2.2 Study Timeline

2.3 Study Phases

2.3.1 Secondary Research

2.3.2 Statistical Analysis

2.3.3 Expert Validation

3. KEY FINDINGS

4. MARKET DYNAMICS

4.1 Drivers

4.1.1 Increasing Demand for Food and Health Supplements

4.1.2 Technological Advancements in Various Application Industries

4.2 Restraints

4.2.1 Fluctuation in raw material prices

4.2.2 Wide availability of immediate substitute

4.3 Opportunities

4.3.1 Potential demand in the Asia-Pacific market

4.3.2 Growing investment in R&D by major companies

4.4 Porter's Five Force Analysis

4.4.1 Bargaining Power of Suppliers

4.4.2 Bargaining Power of Buyers

4.4.3 Threat of New Entrants

4.4.4 Threat of Substitute Products & Services

4.4.5 Degree of Competition

5. MARKET SEGMENTATION

5.1 By End-User

5.1.1 Pharmaceutical

5.1.2 Food & Beverages

5.1.3 Personal care

5.1.4 Others

5.2 By Geography

5.2.1 North America

5.2.2 Europe

5.2.3 Asia-Pacific

5.2.4 South America

5.2.5 Africa

6. COMPETITIVE LANDSCAPE

6.1 Strategy adopted by Key players

6.2 Most active companies in the past five years

6.3 Market Share Analysis

7. COMPANY PROFILES

7.1 DSM

7.1.1 Overview

7.1.2 Financials

7.1.3 Product types

7.1.4 Strategies

7.2 Northeast Pharmaceutical Group

7.2.1 Overview

7.2.2 Financials

7.2.3 Product types

7.2.4 Strategies

7.3 Shandong Luwei Pharmaceutical

7.3.1 Overview

7.3.2 Financials

7.3.3 Product types

7.3.4 Strategies

7.4 Bactolac Pharmaceutical Inc

7.4.1 Overview

7.4.2 Financials

7.4.3 Product types

7.4.4 Strategies

7.5 Aland Nutraceuticals Group

7.5.1 Overview

7.5.2 Financials

7.5.3 Product types

7.5.4 Strategies

7.6 DuPont

7.6.1 Overview

7.6.2 Financials

7.6.3 Product types

7.6.4 Strategies

7.7 FreShine

7.7.1 Overview

7.7.2 Financials

7.7.3 Product types

7.7.4 Strategies

7.8 Luckerkong Biotech

7.8.1 Overview

7.8.2 Financials

7.8.3 Product types

7.8.4 Strategies

7.9 King-pharm

7.9.1 Overview

7.9.2 Financials

7.9.3 Product types

7.9.4 Strategies

7.10 Top science

7.10.1 Overview

7.10.2 Financials

7.10.3 Product types

7.10.4 Strategies

7.11 BASF

7.11.1 Overview

7.11.2 Financials

7.11.3 Product types

7.11.4 Strategies

7.12 Dishman Group

7.12.1 Overview

7.12.2 Financials

7.12.3 Product types

7.12.4 Strategies

7.13 GlaxoSmithKline Plc

7.13.1 Overview

7.13.2 Financials

7.13.3 Product types

7.13.4 Strategies

7.14 CSPC Pharmaceutical Group

7.14.1 Overview

7.14.2 Financials

7.14.3 Product types

7.14.4 Strategies

8. APPENDIX

8.1 Disclaimer

8.2 Sources

8.3 Sources

DSM
Northeast Pharmaceutical Group
Spec-chem
Shandong Luwei Pharmaceutica
Topscience
Bactolac Pharmaceutical Inc.
Luckerkong Biotech
BASF
Aland Nutraceuticals Group
King-pharm
Chengxin Pharma
FreShine